Table 3.
Multi A | Multi B | Multi C | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
VP2-03 | VPTR7 | VP1-11 | VPTR5 | VP1-10 | VPTR1 | VPTR8 | VP1-17 | VPTR4 | VPTR3 | VPTR6 | VP2-07 | |
Clinical isolates (n = 30) | 27 | 16 | 29 | 30 | 1 | 28 | 23 | 30 | 30 | 30 | 5 | 30 |
Percentage (%) | 90.0 | 53.3 | 96.7 | 100.0 | 3.3 | 93.3 | 76.7 | 100.0 | 100.0 | 100.0 | 16.7 | 100.0 |
Oyster isolates (n = 28) | 24 | 17 | 27 | 28 | 23 | 28 | 23 | 28 | 27 | 28 | 4 | 28 |
Percentage (%) | 85.7 | 60.7 | 96.4 | 100.0 | 82.1 | 100.0 | 82.1 | 100.0 | 96.4 | 100.0 | 14.3 | 100.0 |